XML 22 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2019     56,855,002          
Beginning balance at Dec. 31, 2019 $ 2,125,689 $ (35,099) $ 296,483 $ (83,189) $ 1,294,276 $ 617,355 $ (35,099) $ 764
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 83,651         83,651    
Other comprehensive income (loss) 24,304             24,304
Comprehensive loss 107,955              
Repurchase of shares in connection with stock repurchase program (in shares)     (818,886)          
Repurchase of shares in connection with stock repurchase program (24,569)     (24,569)        
Cash dividends (50,134)         (50,134)    
Issuance of common stock for stock-based compensation awards (in shares)     164,371          
Issuance of common stock for stock-based compensation awards (1,686)     6,204 (7,890)      
Stock-based compensation expense 10,577       10,577      
Ending balance (in shares) at Dec. 31, 2020     56,200,487          
Ending balance at Dec. 31, 2020 2,132,733   $ 296,483 (101,554) 1,296,963 615,773   25,068
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 175,892         175,892    
Other comprehensive income (loss) (35,511)             (35,511)
Comprehensive loss 140,381              
Repurchase of shares in connection with stock repurchase program (in shares)     (612,107)          
Repurchase of shares in connection with stock repurchase program (21,315)     (21,315)        
Cash dividends (50,017)         (50,017)    
Issuance of common stock for stock-based compensation awards (in shares)     167,853          
Issuance of common stock for stock-based compensation awards (2,003)     4,842 (6,845)      
Stock-based compensation expense $ 10,074       10,074      
Ending balance (in shares) at Dec. 31, 2021 55,756,233   55,756,233          
Ending balance at Dec. 31, 2021 $ 2,209,853   $ 296,483 (118,027) 1,300,192 741,648   (10,443)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 166,068         166,068    
Other comprehensive income (loss) (198,594)             (198,594)
Comprehensive loss (32,526)              
Cash dividends (49,991)         (49,991)    
Issuance of common stock for stock-based compensation awards (in shares)     196,871          
Issuance of common stock for stock-based compensation awards (2,825)     6,450 (9,275)      
Stock-based compensation expense $ 11,505       11,505      
Ending balance (in shares) at Dec. 31, 2022 55,953,104   55,953,104          
Ending balance at Dec. 31, 2022 $ 2,136,016   $ 296,483 $ (111,577) $ 1,302,422 $ 857,725   $ (209,037)